SC

Savitr Capital

North America, California, United States, San Francisco

Description

Savitr Capital is an investment management firm that specializes in renewable and clean energy companies.

Investor Profile

Savitr Capital has made 12 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Series Unknown (58%)
  • Post Ipo Equity (25%)
  • Series C (8%)
  • Series B (8%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Biopharma
  • Pharmaceutical
  • Health Diagnostics
  • Medical Device
  • Veterinary
  • Mhealth
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Savitr Capital frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 1
Genesys Capital
North America, Ontario, Canada, Toronto
Co-Investments: 2
Adams Street Partners
North America, Illinois, United States, Chicago
Co-Investments: 2
GP
North America, Illinois, United States, Chicago
Co-Investments: 1
Cowen Group
North America, New York, United States, New York
Co-Investments: 1
PC
North America, Ohio, United States, Beachwood
Co-Investments: 1
Baxter Ventures
North America, Illinois, United States, Deerfield
Co-Investments: 1
DB
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2
Latterell Venture Partners
North America, California, United States, San Francisco
Co-Investments: 2
P
North America, Illinois, United States, Northbrook
Co-Investments: 2

What are some of recent deals done by Savitr Capital?

Immunis.AI

Royal Oak, Michigan, United States

Immunis.AI is an immunogenomics company.

Artificial Intelligence (AI)Health CareHealth DiagnosticsWellness
Series UnknownSep 29, 2021
Fidelis Pharmaceuticals

North Brunswick, New Jersey, United States

Fidelis Pharmaceuticals develops and markets pharmaceutical formulations that meet specialized veterinary needs.

PharmaceuticalVeterinary
Series UnknownJul 21, 2021
Amount Raised: $5,129,692
Glytec

Greenville, South Carolina, United States

Glytec is an insulin management software company that helps healthcare providers improve both the quality and the cost of care.

Health CareMedicalSoftwareTherapeutics
Series UnknownApr 26, 2021
Amount Raised: $12,000,000
Biora Therapeutics

Carlsbad, California, United States

Biora Therapeutics is the biotech company.

BiotechnologyHealth CareMedical
Post Ipo EquityDec 8, 2020
Amount Raised: $25,000,000
Aptinyx

Evanston, Illinois, United States

Aptinyx Inc. is a biopharmaceutical company.

BiopharmaBiotechnologyHealth CareMedical
Post Ipo EquityOct 20, 2020
Amount Raised: $48,300,000
BioIQ

Santa Barbara, California, United States

BioIQ is a health improvement technology company that optimizes investments in corporate health and wellness programs.

Health CaremHealth
Series UnknownDec 2, 2019
Amount Raised: $14,000,000
Ancora Heart

Santa Clara, California, United States

Ancora Heart is dedicated to helping people with heart failure feel better and live longer.

Health CareHealth DiagnosticsMedicalMedical Device
Series UnknownMay 30, 2018
Amount Raised: $17,800,000
Heron Therapeutics

Redwood City, California, United States

Heron Therapeutics is a biotechnology firm specializing in polymer-based pharmaceuticals.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityAug 5, 2016
Amount Raised: $50,000,000
Naurex

Evanston, Illinois, United States

Naurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.

BiopharmaBiotechnologyTherapeutics
Series CDec 3, 2014
Amount Raised: $80,000,000
Naurex

Evanston, Illinois, United States

Naurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.

BiopharmaBiotechnologyTherapeutics
Series BDec 17, 2012
Amount Raised: $38,000,000